SCHEMBL9285803

SCHEMBL9285803

CCCCCc1c(C#N)[nH]c2ccccc12

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 5/20 0.54
▸ HSD17B10 Q99714 4/20 0.54
▸ ALDH1A1 P00352 4/20 0.54
▸ HPGD P15428 3/20 0.54
▸ GAA P10253 1/20 0.54
▸ CTSV O60911 2/20 0.48
▸ CTSL P07711 2/20 0.48
▸ RAB9A P51151 1/20 0.48
▸ POLB P06746 1/20 0.46
▸ DRD2 P14416 2/20 0.46
▸ DRD4 P21917 1/20 0.46
▸ DRD3 P35462 1/20 0.46
▸ TSHR P16473 2/20 0.45
▸ CYP1A2 P05177 1/20 0.45
▸ CYP3A4 P08684 1/20 0.45
▸ HTT P42858 1/20 0.44
▸ PABPC1 P11940 1/20 0.44
▸ ALOX15 P16050 1/20 0.44
▸ EGFR P00533 1/20 0.43
▸ HTR2A P28223 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6531687 0.86 KDM4E (0.56) KDM4EHSD17B10ALDH1A1HPGDGAA
SCHEMBL16297142 0.84 DRD2 (0.46) KDM4EHSD17B10ALDH1A1HPGDGAA
SCHEMBL31167422 0.84 DRD2 (0.46) KDM4EHSD17B10ALDH1A1HPGDGAA
SCHEMBL13267812 0.82 DRD2 (0.51) KDM4EHSD17B10ALDH1A1GAAPOLB
SCHEMBL6533131 0.81 KDM4E (0.55) KDM4EHSD17B10ALDH1A1HPGDGAA
SCHEMBL4921978 0.80 KDM4E (0.70) KDM4EHSD17B10ALDH1A1HPGDGAA
SCHEMBL24243724 0.80 HTR2A (0.57) DRD2DRD4DRD3TSHREGFR
SCHEMBL5409935 0.79 CHRNB2 (0.60) KDM4EHSD17B10ALDH1A1HPGDGAA
SCHEMBL8444672 0.79 KDM4E (0.68) KDM4EHSD17B10ALDH1A1HPGDGAA
SCHEMBL8445695 0.79 KDM4E (0.68) KDM4EHSD17B10ALDH1A1HPGDGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5393761-A Treatment of nervous system disorders H. LUNDBECK A/S (DK) 1995-02-28 — — US disclosed
EP-0470039-B1 Novel 3-arylindole and 3-arylindazole derivatives LUNDBECK & CO AS H (DK) 1994-12-07 — — EP disclosed
EP-0470039-A2 Novel 3-arylindole and 3-arylindazole derivatives H. LUNDBECK A/S (DK) 1992-02-05 — — EP disclosed
Send feedback